Online abrufbar
Dienstag, 28.02.2023
19.00 - 20.00 Uhr
19.00 - 20.00 Uhr
Dienstag, 15.11.2022
19.00 - 20.00 Uhr
19.00 - 20.00 Uhr
• Prognostication of Chronic Lymphocytic Leukemia (CLL) using NGS
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)
• Evaluation of Strategies to Leverage NGS-based Minimal Residual Disease (MRD) in Multiple Myeloma (MM) and Acute Lymphoblastic Leukemia (ALL)